Navigation Links
JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
Date:6/21/2012

Vineland, NJ (PRWEB) June 21, 2012

J.G. Finneran Associates, a manufacturer of innovative products for the global chromatography, biotechnology and environmental research communities, has announced that it has appointed Chebios S.r.l. as its exclusive distributor in Italy. The agreement consolidates supply and support of Finneran vials and accessories in a market estimated at €15 to €16 million annually, and represents the latest move for J.G. Finneran as it continues to expand its business in Europe.

“Chebios has the expertise customers look for in a supplier,” says Janet Cohen, International Sales and Marketing Manager at J.G. Finneran Associates, “These guys are extremely familiar with analytical instruments after having worked with them for years, and they know what their customers need. We want that approach to service for our products,” she added.

“Part of our success comes from supplying world class products to our customers, and J.G. Finneran helps us with that,” says Fausto Aldrighetti, the Chebios Marketing Director. “The other part comes from our commitment to service,” he added. Chebios is recognized as a leading supplier of chromatography columns, vials, syringes, standards, reagents and gas generation equipment to laboratories throughout Italy, including the multinational pharmaceutical and chemical manufacturers. With offices in Rome, Naples, Milan and Sicily, Chebios can be reached by telephone at (+39) 06 39.080.601, or by email at chebios(at)chebios(dot)it, or on the web: http://www.chebios.it.

J.G. Finneran Associates designs, engineers and manufactures innovative glass and plastic products in facilities that comply with ISO 9001:2008 quality standards. For more information, visit http://www.jgfinneran.com or contact J.G. Finneran Associates toll-free
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. PinneyAssociates Announces Senior Staff Promotions
2. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
3. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
4. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
5. Elsevier / MEDai Appoints Tom Zajac as New President
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
8. BioStorage Technologies Appoints New Member to Board of Directors
9. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
10. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
11. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Los Angeles, CA (PRWEB) July 10, 2014 ... Analytical and Bioanalytical techniques during 18-20 August, 2014 at ... to critically review the recent developments in Analytical & ... across the globe. , Speaking on this occasion, Dr. ... that Analytica Acta conference is a remarkable one ...
(Date:7/10/2014)... , July 10, 2014  Kainos Capital, a firm ... today announced that it has acquired the Slim-Fast brand ... the business. Terms of the transaction were not disclosed. ... meal replacement business that markets ready-to-drink shakes, powders, bars ... America and in the United ...
(Date:7/10/2014)... help in the fight against terrorism with the creation ... explosives with the use of light and special glass ... Actuators B: Chemical , the researchers describe a novel ... as low as 6.3 ppm (parts per million). It ... , "Traditionally explosives detection has involved looking for metals ...
(Date:7/10/2014)... batteries that power our laptops and electric vehicles could ... charge with the help of a sponge-like silicon material. ... the graphite traditionally used in one of the battery,s ... energy storage capacity of graphite. A paper describing the ... today in Nature Communications . , "Silicon has ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3
... the diuretic hydrochlorothiazide (HCTZ) in ... in significant additional blood pressure reductions compared to either drug alone ... or more, medicines - single-tablet combinations simplify treatment by reducing ... number of pills patients take, EAST ...
... Named ,Illinois Rising Stars, CHICAGO, Jan. 18 ... property law firms in the United States, is,pleased to ... "Illinois,Super Lawyers" for 2008 in a survey conducted by ... designated "Rising Stars" in,Illinois., Meredith Martin Addy, chair ...
... Jan. 18 Abbott (NYSE: ABT ),announced today ... for its fully automated HTLV-I/HTLV-II blood screening test,for use ... for use by,laboratories to screen individual donations of blood ... Type I and/or human T --,lymphotropic virus Type II ...
Cached Biology Technology:Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 2Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 4Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 5Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 'Illinois Super Lawyers' 2Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II 2Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II 3
(Date:7/11/2014)... evidence has demonstrated that transplantation of mesenchymal stem cells ... or mouse models of Alzheimer,s disease (AD) and improve ... ischemia. Few studies are reported on the therapeutic effect ... AD and on the effect on oxidative injury and ... Yan and her team, School of Life Sciences, Tsinghua ...
(Date:7/11/2014)... that cannabinoid receptor type 1 can inhibit ... and reduce neurotransmitter release. However, some scholars ... increase extracellular Ca2+ influx and increase neurotransmitter ... Tongji Hospital Affiliated to Tongji Medical College, ... used whole cell voltage-clamp and calcium imaging ...
(Date:7/11/2014)... brains of all vertebrates, information is transmitted through ... chemical signal to be passed from one brain ... most abundant type of synapse, can be either ... learning, memory, perception and cognition, and the balance ... function. For instance, every time we learn ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2
... May 3, 2010-Conventional agriculture production relies heavily on fossil ... a low cost. However, the uncertain future of fossil ... energy efficiencies in other cropping systems. Most of ... of corn and soybean with heavy inputs of fertilizer, ...
... May 3, 2010 Genes interact in complex networks that ... through relationships. Researchers are now discovering how biological networks ... published today in Genome Research ( www.genome.org ), ... shedding light on how interactions go awry in disease. ...
... May 2 Scientists at the University of Pittsburgh School ... a catch of new mediators that not only can explain ... novel treatments for a host of diseases linked to inflammatory ... of Nature Chemical Biology . There is strong ...
Cached Biology News:Reducing fossil energy use on the farm 2Reducing fossil energy use on the farm 3MicroRNA network study implicates rewired interactions in cancer 2Pitt pharmacologists go on a molecular fishing trip and hook prize catch 2